Hib vaccine

BIOLOGICAL5 trials

Sponsors

Jiangsu Province Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, China, Tanabe Pharma Corporation

Conditions

Bacterial MeningitisDiphtheriaGroup A, C Polysaccharide MeningitisImmunization; InfectionInfluenzaMeningitisNasopharyngeal DiseasesPertussis

Phase 3

Immunogenicity and Safety of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine in Infants and Children

CompletedNCT01428908

Jiangsu Province Centers for Disease Control and PreventionGroup A, C Polysaccharide Meningitis, Type b Haemophilus Influenza

Start: 2011-09-30End: 2012-01-31Updated: 2012-04-19

Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine

CompletedNCT01580033

Jiangsu Province Centers for Disease Control and PreventionInfluenza, Meningitis

Start: 2012-04-30End: 2012-11-30Updated: 2013-05-08

Phase 3 Study of BK1310 in Healthy Infants

CompletedNCT02992925

Tanabe Pharma CorporationImmunization; Infection

Start: 2016-11-30End: 2018-11-30Updated: 2026-01-06

Confirmatory Study of BK1310 in Healthy Infants

CompletedNCT03891758

Tanabe Pharma CorporationBacterial Meningitis, Diphtheria, Pertussis +2

Start: 2019-04-01End: 2020-08-10Updated: 2026-01-06

Unknown Phase

PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae

CompletedNCT02133469

Centers for Disease Control and Prevention, ChinaNasopharyngeal Diseases, Streptococcal Pneumonia, Vaccination Adverse Event

Start: 2012-06-30End: 2014-05-31Updated: 2016-05-20